由SRSF9稳定的EEF1D通过增强扩散和转移促进结直肠癌
Rui Wang1, Chi Lv2, Donghao Li2
1Department of Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
International journal of cancer
|May 21, 2024
概括
细胞翻译延长因子1三角形 (EEF1D) 通过增强细胞增殖和转移,促进结直肠癌 (CRC) 的进展. 针对EEF1D可能为CRC治疗提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因,其分子机制仍在研究中.
- 细胞翻译延长因子1三角形 (EEF1D) 与各种癌症有关,但其在CRC中的作用尚未完全理解.
研究的目的:
- 阐明EEF1D在结直肠癌进展中的作用和调节机制.
- 调查EEF1D作为CRC治疗的潜在分子标.
主要方法:
- 在CRC组织中评估EEF1D表达.
- 进行了EEF1D的体外和体内功能分析.
- 利用RNA免疫沉,RNA下拉试验和蛋白质组学来识别调节机制.
主要成果:
- 在人体CRC组织中,EEF1D表达显著上调.
- EEF1D过度表达促进了CRC细胞的增殖和转移,而敲击抑制了这些过程.
- 鉴定出SRSF9是EEF1D的调节者,它与3'UTR结合,并上调其表达.
结论:
- 在促进结直肠癌进展方面,EEF1D发挥着至关重要的作用.
- EEF1D代表了开发新型CRC治疗的潜在分子标.
相关概念视频
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


